Introduction: Personalizing risk stratification in bladder cancer: Moving away from "the eyeball test" and embracing objective quantification of risk.

Introduction: Personalizing risk stratification in bladder cancer: Moving away from "the eyeball test" and embracing objective quantification of risk. Urol Oncol. 2020 Jun 27;: Authors: Psutka SP PMID: 32600927 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32600927?dopt=Abstract

Source: Urologic Oncology - June 26, 2020 Category: Urology & Nephrology Authors: Psutka SP Tags: Urol Oncol Source Type: research

More News: Bladder Cancer | Cancer | Cancer & Oncology | Urology & Nephrology